Most cost questions get answered with a single figure for a single month. That is rarely how it works out. The cost of care with a prescription medicine is a set of pieces that repeat, and some of those pieces change partway through the year.
Important safety information. Tirzepatide is the active ingredient in Mounjaro and Zepbound, which are FDA-approved prescription medicines from Eli Lilly and Company. Semaglutide is the active ingredient in Ozempic and Wegovy, from Novo Nordisk A/S. These branded medicines carry a boxed warning about the risk of thyroid C-cell tumors. They should not be used by people with a personal or family history of medullary thyroid carcinoma, or by people with Multiple Endocrine Neoplasia syndrome type 2. Serious risks can include pancreatitis, gallbladder problems, acute kidney injury, severe stomach and intestinal reactions, serious allergic reactions, low blood sugar when taken with certain other diabetes medicines, and diabetic retinopathy complications. Read the official Prescribing Information and Medication Guide for each one: Mounjaro, Zepbound, Ozempic, and Wegovy.
This page is general information, not medical advice. Talk to a licensed clinician about your situation.
The pieces that make up the total
The pharmacy charge for the prescription is the piece most people think of first. It depends on the exact product, strength, quantity, supply period, pharmacy, and payment method.
The clinical program fee is separate. It pays for evaluation, follow-up, and support, and it exists whether or not a prescription is written.
Laboratory work may be ordered when a clinician decides it is appropriate, and it is usually billed by the laboratory rather than by the clinic.
Supplies and shipping sometimes appear as their own charges. Ask up front whether they do.
Add those pieces before comparing any two options. A low figure for one piece can sit next to a high figure for another.
Why the total moves during the year
A deductible resets. Early in a plan year, a patient may pay a negotiated price in full until the deductible is met, and pay far less after.
A formulary changes. Plans update their covered lists and their clinical criteria, and a medicine covered in one year may be treated differently in the next.
A prescription changes. Dose and quantity can change as a clinician manages care, and the pharmacy charge changes with them.
A savings program ends or its terms shift. These programs have expiration dates, maximum benefits, and eligibility conditions, and some patients are excluded from some of them.
None of these are surprises if you expect them. All of them look like a surprise if you budgeted from one month's total.
What the plan decides, and what it does not
Plans publish a formulary and clinical coverage criteria. A plan may require prior authorization, limit quantities, apply step therapy, or direct patients to a preferred pharmacy.
Ask member services these questions, and write down the answers with the date:
- Is this exact prescription on the current formulary for its labeled use?
- What coverage criteria or prior authorization paperwork applies?
- Which pharmacies are in network or preferred?
- How do the deductible and cost-sharing apply right now?
A benefits estimate is not a decision. The plan reviews the claim under its own terms, and approval and payment are determined by the plan. If an insured patient pays outside the plan, that amount may not count toward the deductible or out-of-pocket maximum, so confirm that with the plan administrator rather than assuming.
Eli Lilly publishes current manufacturer terms on its pricing FAQ and savings and coverage page. Those terms change, so check the official source when the decision is being made.
Compounded tirzepatide is costed differently
Compounded tirzepatide is prepared by a pharmacy rather than approved as a finished drug product, so there is no manufacturer list price, no formulary position, and no manufacturer savings program behind it.
Compounded medications are not FDA-approved. FDA does not review them for safety, effectiveness, or manufacturing quality.
Compounded tirzepatide is not Zepbound, not Mounjaro, not Ozempic and not Wegovy. It is not a generic version of any approved drug, and it is not interchangeable with one. FDA's overview of human drug compounding describes the category.
It may be dispensed only pursuant to a valid prescription issued by a licensed clinician after a clinical evaluation, and only from a state-licensed pharmacy. Because of that, no cost can be quoted as final before an evaluation has happened and a clinician has decided what, if anything, is appropriate.
Treat any figure in this category as a starting question rather than an answer: who charges it, which pharmacy dispenses, what period it covers, and what it leaves out.
Body Good service fees, stated plainly
Body Good's prices are service fees for the program described at intake. They cover the clinical evaluation and the ongoing care and support in that program. They are not the price of medication and are not a quote for any individual. Eligibility is determined by a clinician.
The cost of medication is separate and is not included in a Body Good service fee. The dispensing pharmacy charges for what it fills, and a laboratory charges for its own work.
Body Good provides coverage support, which means help checking benefits and preparing paperwork a plan requests. It does not determine what a plan approves or pays.
This site is an information and pricing overview only. It takes no payment, collects no health information, and runs no intake form. Intake happens on joinbodygood.com.
When cost pressure shows up mid-treatment
This happens, and it is worth planning for. The wrong response is to stretch doses, skip refills, share a prescription, or stop without telling anyone. Those choices carry clinical consequences that have nothing to do with money.
The right first calls are the prescribing clinician and the pharmacist. A clinician can review whether the plan is still appropriate, whether different paperwork is worth filing, or whether another approach fits. The pharmacy can explain exactly how a charge was processed and what it covered.
Keep the service fee, pharmacy charge, and laboratory charge on separate lines throughout. When a total changes, separate lines show which piece moved and who can explain it.
Frequently asked questions
What is the monthly cost of tirzepatide?
There is no single monthly figure. It depends on the exact product and whether it is FDA-approved or compounded, the quantity and supply period, the pharmacy, the payment method, and the plan's current rules.
Why did my cost change after a few months?
Common causes are a deductible reset or being met, a dose or quantity change, a formulary or criteria update, a pharmacy change, or a savings program condition. Ask the pharmacy and the plan which one applied.
Does Body Good's fee include the medication?
No. A Body Good service fee covers the program described at intake, and the cost of medication is separate. Begin Body Good's clinical intake to have a clinician review your situation.
Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Body Good is not affiliated with, endorsed by, sponsored by, or authorized by Eli Lilly and Company or Novo Nordisk A/S. All trademarks are the property of their respective owners.